medline.ch Onkologie Haut

	Recent approaches for the treatment of uveal melanoma: Opportunities and challenges. Crit Rev Oncol Hematol Khan SA, Almalki WH, Arora SJ, Kesharwani P. PMID: 38040071 [PubMed - as supplied by publisher]
	Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches. Can J Ophthalmol Dockery PW, DeSimone JD, Liu CK, Achuck K, Hamburger J, Bas Z, Shields CL. PMID: 38040029 [PubMed - as supplied by publisher]
	Treatment of Acral and Mucosal Melanoma: Current and Emerging Targeted Therapies. Crit Rev Oncol Hematol Zhang J, Tian H, Mao L, Si L. PMID: 38036156 [PubMed - as supplied by publisher]
	A multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing. Can J Ophthalmol Pike SB, Reid MW, Peng CC, Chang C, Xu BY, Gombos DS, Patel S, Xu L, Berry JL. PMID: 38036045 [PubMed - as supplied by publisher]
	Polarimetric imaging combining optical parameters for classification of mice non-melanoma skin cancer tissue using machine learning. Heliyon Pham TT, Luu TN, Nguyen TV, Huynh NT, Phan QH, Le TH. PMID: 38034801 [PubMed]
	Exploring the Changing Diagnostic Criteria of Gorlin-Goltz Syndrome: A Case Report. Oncology (Williston Park) Shetty SK, Doddawad VG, Sundar S, S S. PMID: 38032303 [PubMed - indexed for MEDLINE]
	Melanocytic tumors with spitzoid morphology: correlation of clinicopathologic features and FISH analysis. Turk J Med Sci Kapi, Ülgen ÖA, , Demirkesen C. PMID: 38031947 [PubMed - indexed for MEDLINE]
	Deep-learning-based survival prediction of patients with lower limb melanoma. Discov Oncol Zhang J, Yu H, Zheng X, Ming WK, Lak YS, Tom KC, Lee A, Huang H, Chen W, Lyu J, Deng L. PMID: 38030951 [PubMed]
	Histological Assessment of Synovial Sarcoma Before and After TCR-T Cell Therapy and Cryoablation: A Case Report. Anticancer Res Asanuma K, Ishihara M, Nakamura T, Uchida K, Hagi T, Kageyama S, Shiku H, Sudo A. PMID: 38030212 [PubMed - indexed for MEDLINE]
	A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF(V600) mutant advanced melanoma (INTERIM). Eur J Cancer Dayimu A, Gupta A, Matin RN, Nobes J, Board R, Payne M, Rao A, Fusi A, Danson S, Eccles B, Carser J, Brown CO, Steven N, Bhattacharyya M, Brown E, Gonzalez M, Highley M, Pickering L, Kumar S, Waterston A, Burghel G, Demain L, Baker E, Wulff J, Qian W, Twelves S, Middleton M, Corrie P. PMID: 38029480 [PubMed - as supplied by publisher]
	The impact of the COVID-19 pandemic on the characteristics of melanoma: a single-centre cohort study. Postepy Dermatol Alergol , S, Sikorska M, Sobjanek M. PMID: 38028407 [PubMed]
	Proposing a hybrid technique of feature fusion and convolutional neural network for melanoma skin cancer detection. J Pathol Inform Rahman MM, Nasir MK, Nur-A-Alam M, Khan MSI. PMID: 38028129 [PubMed]
	Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis. Front Pharmacol Sheng F, Yan Y, Zeng B. PMID: 38026956 [PubMed]
	A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma. J Contemp Brachytherapy Miguel D, de Frutos JM, Alonso P, García-Álvarez C, Saornil MA, Diezhandino P, Garavis MI, Valencia P. PMID: 38026075 [PubMed]
	Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib. Drug Des Devel Ther Li S, Wang H. PMID: 38024530 [PubMed - indexed for MEDLINE]
	Cost items in melanoma patients by clinical characteristics and time from diagnosis. Front Oncol Buja A, Cozzolino C, Zanovello A, Geppini R, Miatton A, Zorzi M, Manfredi M, Bovo E, Del Fiore P, Tropea S, dall'Olmo L, Rossi CR, Mocellin S, Rastrelli M, Rugge M. PMID: 38023154 [PubMed]
	Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma. Adv Pharm Bull Saeidi Z, Giti R, Rostami M, Mohammadi F. PMID: 38022807 [PubMed]
	A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. Front Immunol Smith KER, Peng KW, Pulido JS, Weisbrod AJ, Strand CA, Allred JB, Newsom AN, Zhang L, Packiriswamy N, Kottke T, Tonne JM, Moore M, Montane HN, Kottschade LA, McWilliams RR, Dudek AZ, Yan Y, Dimou A, Markovic SN, Federspiel MJ, Vile RG, Dronca RS, Block MS. PMID: 38022659 [PubMed - indexed for MEDLINE]
	Advancements in the treatment of mycosis fungoides and SÃ©zary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors. Front Immunol Quadri I, Reneau JC, Hanel W, Chung CG. PMID: 38022633 [PubMed - indexed for MEDLINE]
	Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers. Front Immunol Brozos-Vázquez EM, Rodríguez-López C, Cortegoso-Mosquera A, López-Landrove S, Muinelo-Romay L, García-González J, López-López R, León-Mateos L. PMID: 38022574 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 129683

Seite 1 von 6485

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung